Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1967 1
1969 2
1972 1
1974 1
1975 2
1977 2
1978 1
1979 1
1980 2
1982 2
1983 2
1985 2
1987 6
1988 4
1989 6
1990 4
1991 3
1992 7
1993 5
1994 7
1995 4
1996 7
1997 8
1998 7
1999 2
2000 7
2001 11
2002 6
2003 11
2004 14
2005 6
2006 16
2007 13
2008 23
2009 26
2010 40
2011 70
2012 67
2013 82
2014 77
2015 76
2016 95
2017 85
2018 81
2019 96
2020 89
2021 113
2022 108
2023 143
2024 141

Text availability

Article attribute

Article type

Publication date

Search Results

1,407 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. Among authors: patil r. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Reversal of dual epigenetic repression of non-canonical Wnt-5a normalises diabetic corneal epithelial wound healing and stem cells.
Shah R, Spektor TM, Weisenberger DJ, Ding H, Patil R, Amador C, Song XY, Chun ST, Inzalaco J, Turjman S, Ghiam S, Jeong-Kim J, Tolstoff S, Yampolsky SV, Sawant OB, Rabinowitz YS, Maguen E, Hamrah P, Svendsen CN, Saghizadeh M, Ljubimova JY, Kramerov AA, Ljubimov AV. Shah R, et al. Among authors: patil r. Diabetologia. 2023 Oct;66(10):1943-1958. doi: 10.1007/s00125-023-05960-1. Epub 2023 Jul 18. Diabetologia. 2023. PMID: 37460827 Free PMC article.
New Boron Delivery Agents.
Beck-Sickinger AG, Becker DP, Chepurna O, Das B, Flieger S, Hey-Hawkins E, Hosmane N, Jalisatgi SS, Nakamura H, Patil R, Vicente MDGH, Viñas C. Beck-Sickinger AG, et al. Among authors: patil r. Cancer Biother Radiopharm. 2023 Apr;38(3):160-172. doi: 10.1089/cbr.2022.0060. Epub 2022 Nov 9. Cancer Biother Radiopharm. 2023. PMID: 36350709 Free PMC article. Review.
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB).
Ostwal V, Mandavkar S, Bhargava P, Srinivas S, Kapoor A, Shetty O, Kannan S, Chaugule D, Patil R, Parulekar M, Nashikkar C, Ankathi SK, Baheti AD, Mehta D, Kaushal RK, Yadav S, Shah A, Patkar S, Goel M, Ramaswamy A. Ostwal V, et al. Among authors: patil r. J Clin Oncol. 2024 Mar 1;42(7):800-807. doi: 10.1200/JCO.23.01193. Epub 2023 Nov 9. J Clin Oncol. 2024. PMID: 37944079 Clinical Trial.
Graphene in 3D Bioprinting.
Patil R, Alimperti S. Patil R, et al. J Funct Biomater. 2024 Mar 25;15(4):82. doi: 10.3390/jfb15040082. J Funct Biomater. 2024. PMID: 38667539 Free PMC article. Review.
1,407 results